Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Total Non-Current Liabilities came in at $110.6 million in Q2 2026, up 1.8% on a YoY basis from $108.7 million in Q2 2025, and up 6.52% quarter-over-quarter from $103.9 million in Q1 2026.
Analysis
Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has reported Total Non-Current Liabilities for 7 consecutive years, with $110.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities rose 1.8% year-over-year to $110.6 million; the trailing twelve-month figure through Jun 2026 stood at $110.6 million (up 1.8% YoY), and the FY2025 full-year result was $100.2 million, down 3.75% from the prior year.
- Total Non-Current Liabilities rose to $110.6 million in Q2 2026 per TMCI's latest filing, from $103.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $116.2 million in Q1 2024 and bottomed at $59.6 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $101.1 million across 5 years, with a median of $103.2 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities jumped 135.5% in 2022, then declined 13.62% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $98.5 million in 2022, then gained by 15.66% to $113.9 million in 2023, then retreated by 8.61% to $104.1 million in 2024, then retreated by 3.75% to $100.2 million in 2025, then climbed by 10.41% to $110.6 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $110.6 million, $103.9 million, and $100.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn | 110.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110.63 Mn |
| Mar 31, 2026 | 103.86 Mn |
| Dec 31, 2025 | 100.20 Mn |
| Sep 30, 2025 | 107.21 Mn |
| Jun 30, 2025 | 108.67 Mn |
| Mar 31, 2025 | 100.35 Mn |
| Dec 31, 2024 | 104.11 Mn |
| Sep 30, 2024 | 107.85 Mn |
| Jun 30, 2024 | 113.82 Mn |
| Mar 31, 2024 | 116.18 Mn |
| Dec 31, 2023 | 113.92 Mn |
| Sep 30, 2023 | 102.46 Mn |
| Jun 30, 2023 | 99.65 Mn |
| Mar 31, 2023 | 91.53 Mn |
| Dec 31, 2022 | 98.50 Mn |
| Sep 30, 2022 | 94.24 Mn |
| Jun 30, 2022 | 87.01 Mn |
| Mar 31, 2022 | 59.61 Mn |
| Dec 31, 2021 | 47.58 Mn |
| Sep 30, 2021 | 40.02 Mn |